Here’s a copy of a letter I sent to Dr. Reilly in relation to the extortionate fees being charged by the regulator. They currently are running a surplus of just short of €2 million per year. That means they could charge each community pharmacy €1,250 per year instead of €2,250 per year and still be generating a surplus. I intend to circulate this to every member of the council as well. So that the next time that they decide to do nothing they cannot say that “nobody told us.”
I would urge you all to do likewise.
Dear Minister Reilly,
I am writing to ask you to reduce the annual registration fees payable to the Pharmacy Regulator, the Pharmaceutical Society of Ireland (PSI). As you can see from the table below the registration fees for premises and individuals are far higher in Ireland than those payable in both the UK and Northern Ireland. I feel that the fees payable to the PSI should be reduced to rates similar to those paid by pharmacists in other EU countries.
Premises Ireland €2250 UK(1) £221 (€265) Northern Ireland(2) £155 (€185.89)
Pharmacist Ireland €400 UK(1) £240 (€287.82) Northern Ireland(2) £372 (€446.12)
(Exchange rate – 21/11/13)
On June 26 2013, the Health and Social Professionals Council (CORU) reduced the annual registration fee by 3€195 and set it at €100 for the next 3 years and agreed to refund any members who had paid the annual fee of €295. I would appreciate if you could instruct the PSI to implement a similar reduction for both the individual pharmacists and pharmacy premises as soon as possible.
I would also appreciate if you could instruct the PSI to implement a system allowing for payment in instalments to ease the cash flow burden imposed on pharmacists due to the implementation of a once-off annual payment system.
In light of the current economic climate, the fact that the PSI reported an annual excess of €1,944,324 (4) for the year ending 31/12/12 and the recent reductions in fees paid to pharmacists, I would ask that you give serious consideration to my application and ask the Pharmacy regulator to implement an appropriate deduction in fees payable as soon as possible.
I look forward to hearing from you.
(1)Ref – General Pharmaceutical Council
ees (cited 21/11/13)
(2)Ref – PSNI
-2013141.pdf (cited 21/11/13)
(3)Ref – CORU
(4)Ref – PSI http://www.thepsi.ie/tns/publications/core-publications.aspx (21/11/13)